Parabilis Medicines, Inc.
PBLS
$28.80
$2.449.26%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 329.04M | 87.98M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 3.03M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 332.07M | -- | |||
|
|
|||||
| Total Current Assets | 332.07M | -- | |||
| Net Property, Plant & Equipment | 43.93M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 8.17M | -- | |||
| Total Assets | 384.17M | -- | |||
|
|
|||||
| Total Accounts Payable | 15.04M | -- | |||
| Total Accrued Expenses | 16.36M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 17.43M | -- | |||
| Total Finance Division Other Current Liabilities | 5.41M | -- | |||
| Total Other Current Liabilities | 5.41M | -- | |||
| Total Current Liabilities | 54.24M | -- | |||
|
|
|||||
| Total Current Liabilities | 54.24M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 35.71M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 50.00M | -- | |||
| Total Liabilities | 139.95M | -- | |||
|
|
|||||
| Common Stock & APIC | 16.50M | -- | |||
| Retained Earnings | -586.82M | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -570.32M | -383.94M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 814.54M | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 814.54M | 440.38M | |||
|
|
|||||
| Total Common Equity | -570.32M | -383.94M | |||
| Total Preferred Equity | 814.54M | 440.38M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 244.22M | 56.44M | |||
|
|
|||||